CRUCELL ANNOUNCES WHO PREQUALIFICATION FOR QUINVAXEM VACCINE

Dutch biotechnology company Crucell N.V. announced today that Quinvaxem, its fully liquid pentavalent vaccine co-developed with Novartis Vaccines and Diagnostics, has been granted 'prequalification' by the World Health Organization (WHO). Yahoo Finance (http://biz.yahoo.com/iw/060926/0166679.html)